These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 15252744

  • 1. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
    Lawrenz T, Kuhn H.
    Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
    [Abstract] [Full Text] [Related]

  • 2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patient.
    Höblinger A, Tiemann K, Nickenig G, Sauerbruch T, Lammert F.
    Z Gastroenterol; 2008 Oct 23; 46(10):1194-7. PubMed ID: 18937189
    [Abstract] [Full Text] [Related]

  • 7. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
    Gao YC, Li Y, Han ZH, Zhang XL, Zhao H, Jiang TY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr 23; 35(4):333-6. PubMed ID: 17711659
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
    Kuhn H, Gietzen FH, Leuner C, Schäfers M, Schober O, Strunk-Müller C, Obergassel L, Freick M, Gockel B, Lieder F, Raute-Kreinsen U.
    Z Kardiol; 2000 Apr 23; 89 Suppl 4():IV41-54. PubMed ID: 10810776
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H, Faber L.
    Eur J Echocardiogr; 2000 Dec 23; 1(4):277-80. PubMed ID: 11916606
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New approach to septal ablation: glue (cyanoacrylate) septal ablation.
    Oto A, Aytemir K, Deniz A.
    Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):1021-5. PubMed ID: 17525960
    [Abstract] [Full Text] [Related]

  • 19. Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?
    Riedlbauchová L, Janoušek J, Veselka J.
    J Invasive Cardiol; 2013 Jun 01; 25(6):E128-32. PubMed ID: 23735367
    [Abstract] [Full Text] [Related]

  • 20. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H, Wang P, Xing Y, Peng F, Jiang J, Yang B, You B, Qiu Y, Lee JD.
    J Electrocardiol; 2007 Oct 01; 40(4):356.e1-6. PubMed ID: 17316677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.